Chisato M Yamazaki Selected Research

Therapeutics

1/2022	Homogeneous antibody-angiopep 2 conjugates for effective brain targeting.
1/2022	An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody-Drug Conjugates.
8/2015	A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chisato M Yamazaki Research Topics

Disease

5	Neoplasms (Cancer) 01/2024 - 08/2015
2	Neoplasm Metastasis (Metastasis) 10/2021 - 08/2015
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Breast Neoplasms (Breast Cancer) 10/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2020
1	Peritoneal Neoplasms 08/2015
1	Drug-Related Side Effects and Adverse Reactions 08/2015
1	Ovarian Neoplasms (Ovarian Cancer) 08/2015

Drug/Important Bio-Agent (IBA)

5	Immunoconjugates (Immunoconjugate)IBA 01/2024 - 11/2020
2	Peptides (Polypeptides)IBA 01/2022 - 08/2015
2	Valine (L-Valine)FDA Link 01/2022 - 01/2018
2	CitrullineIBA 01/2022 - 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	AntibodiesIBA 01/2022
1	Ado-Trastuzumab EmtansineIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 08/2015
1	NeuropilinsIBA 08/2015

Therapy/Procedure

3	Therapeutics 01/2022 - 08/2015
2	Drug Therapy (Chemotherapy) 10/2021 - 08/2015